| Full Name | Angela Brown |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1600 6th Ave, York, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851177208 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN267929 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Brown, LPN 1600 6th Ave Ste 108, York, PA 17403-2626 Ph: (717) 356-4705 | Angela Brown, LPN 1600 6th Ave, York, PA 17403-2626 Ph: (717) 356-4705 |
News Archive
Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to scientists and strategists in the booming immuno-oncology combination field of study.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
Throughout our lives we are exposed to an enormous range of man-made chemicals, from food, water, medicines, cosmetics, clothes, shoes and the air we breathe. At the request of the EU, researchers at the University of Gothenburg, Sweden, have looked at the risk of "chemical cocktails" and have proposed a number of measures that need to be implemented in the current practice of chemical risk assessment.
VIRxSYS Corporation, a privately-held biotechnology company with proprietary RNA payload and lentiviral vector delivery platform technologies, today announced that the United States Patent and Trademark Office has issued the Company two patents for its SMaRT RNA platform technology, capable of reprogramming or repairing genes to create, increase or change protein expression.
In a review of its popular impotence treatment Viagra, Pfizer announced on Monday that it had found no evidence of increased risk of blindness among patients taking the erectile dysfunction drug.
› Verified 7 days ago
Danielle J Brenneman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 Fax: 717-840-2740 | |
Ms. Christine Falu, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 | |
Emylee Aleah Waterman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 Fax: 717-840-2741 | |
Tammy Daugherty, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2740 Fax: 717-840-2740 | |
Paul Harry Keares, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 | |
Susan Kaye Grimek, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2740 | |
Jan Marie Kaufhold, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 |